AIFA autorizza il vaccino bivalente Comirnaty Original per le varianti Omicron BA.4-5
BioNTech SE on X: "We completed, together with @Pfizer, the submission to the @US_FDA requesting Emergency Use Authorization (EUA) of a 10-µg booster dose of the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for
FDA recommends including omicron subvariants BA.4 and BA.5 in fall Covid boosters
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.1) COVID-19 vaccine | Australian Government Department of Health and Aged Care
Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster | Nature Medicine
FDA approves 2nd omicron booster for high-risk people
Covid-19, Fda autorizza i booster bivalenti di Pfizer/BioNTech e M
CDC recommends updated Covid-19 boosters to target Omicron strains - POLITICO
CDC recommends new COVID booster for all Americans over 6 months amid rising cases, hospitalizations - ABC News
Health Canada approves Pfizer's new bivalent COVID-19 vaccine | CBC News
RACGP - Second bivalent booster receives ATAGI recommendation
Pfizer and BioNTech seek emergency use authorization for Omicron BA.4/5-adapted booster vaccine
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
Second Omicron Booster Authorized | MedPage Today
Pfizer Canada - Another step forward in the fight against COVID-19: Health Canada has authorized COMIRNATY Original & Omicron BA.4/BA.5 (Pfizer-BioNTech bivalent, Omicron BA.4/BA.5-adapted COVID-19 vaccine) as a booster dose for Canadians
Pfizer asks FDA for approval to expand omicron booster to 5- to 11-year-olds | PBS NewsHour
Updated Covid-19 booster shots expanded to children as young as 5 | CNN
New Omicron Booster Shots: What You Need to Know - YouTube
FDA vaccine advisers 'disappointed' and 'angry' that early data about new Covid-19 booster shot wasn't presented for review last year | CNN
News - CHMP Recommends Additional Authorisation Modification of Comirnaty (BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
Pfizer asks FDA to authorize Covid booster shots that target omicron BA.5 for people ages 12 and older
Covid: Aifa approva il vaccino bivalente Comirnaty sviluppato contro Omicron 4-5 | Sanità24 - Il Sole 24 Ore
RACGP - Updating COVID-19 vaccines 'on the agenda', but not sustainable
